AgingResearch.NewsJoin free

Alzheimer's Prevention Initiative Preclinical Composite Cognitive test

There is 1 paper on Alzheimer's Prevention Initiative Preclinical Composite Cognitive test in aging research: 1 observational study in people.

Biomarker

1 paper studies it1 finding

See all 1 papers on Alzheimer's Prevention Initiative Preclinical Composite Cognitive test

“sensitive to preclinical AD decline up to 11 years prior to diagnosis of the clinical stages of AD”
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's diseaseAlzheimer's research & therapy2020doi:10.1186/s13195-020-00633-2
  • Humans1

Associations

1

Preclinical Alzheimer's disease decline

downin humans1

1 study

  1. Alzheimer's Prevention Initiative Preclinical Composite Cognitive test predicts preclinical Alzheimer's disease decline in humans (up to 11 years prior to diagnosis).

    “sensitive to preclinical AD decline up to 11 years prior to diagnosis of the clinical stages of AD”

    Humansup to 11 years before diagnosis

    The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease

    Alzheimer's research & therapy

Latest

Related